𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Enzyme immunoassay discrimination of a new angiotensin-converting enzyme (ACE) inhibitor, cilazapril, and its active metabolite

✍ Scribed by Hiroshi Tanaka; Yoshio Yoneyama; Minoru Sugawara; Isao Umeda; Yumiko Ohta

Publisher
John Wiley and Sons
Year
1987
Tongue
English
Weight
402 KB
Volume
76
Category
Article
ISSN
0022-3549

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Determination of the angiotensin-convert
Determination of the angiotensin-converting enzyme inhibitor quinapril and its metabolite quinaprilat in pharmaceuticals and urine by capillary zone electrophoresis and solid-phase extraction
✍ JosΓ© Angel Prieto; Rosa MarΓ­a Alonso; Rosa MarΓ­a JimΓ©nez πŸ“‚ Article πŸ“… 2002 πŸ› John Wiley and Sons 🌐 English βš– 443 KB πŸ‘ 2 views

Quinapril is an antihypertensive drug commonly used in the treatment of hypertension and congestive heart failure. In this work, a capillary zone electrophoresis system is optimized for the analysis of quinapril and its active metabolite quinaprilat in urine, as well as for the determination of the

Study on pharmacokinetics of a new bilia
Study on pharmacokinetics of a new biliary excreted oral angiotensin converting enzyme inhibitor, temocapril (CS-622) in humans
✍ H. Suzuki; T. Kawaratani; H. Shioya; Y. Uji; Dr T. Saruta πŸ“‚ Article πŸ“… 1993 πŸ› John Wiley and Sons 🌐 English βš– 491 KB πŸ‘ 2 views

## Abstract Despite the usefulness of angiotensin converting enzyme (ACE; EC 3.4.15.1) inhibitors for patients with renal insufficiency, some hesitation has been exercised in applying ACE inhibitors to the treatment of such patients because most ACE inhibitors are excreted mainly into the urine. In